网页
综合
更新时间 2026-11-14 10:44:35
Finance | HK & US Market News | NewTimeSpace
On 13 Nov 2026, AB&B BIO-TECH-B (02627.HK) said China's CDE approved the IND for its tetanus vaccine candidate on 12 November.
On 13 Nov 2026, CLOUD FACTORY (02512.HK) disclosed RMB96m and RMB145m server buys, both discloseable transactions with equipment delivered.
On 13 Nov 2026, BOCOM INTL (03329.HK) said its unit bought US$12m of Standard Chartered notes at 99.386 for about HK$93.6m, a discloseable transaction.
On 13 Nov 2026, LINGBAO GOLD (03330.HK) detailed a A$410m cash-plus-royalty deal for the remaining 50%-1 stake, with NSR royalties capped at A$244m.
On 13 Nov 2026, JLMAG (06680.HK) said its 20,000-tonne Baotou magnet project passed fire inspection; capacity will reach 60,000 tonnes a year by end-2027.
On 13 Nov 2026, HOPE LIFE INT (01683.HK) delayed its circular on the convertible bond deal to 20 November and extended the long-stop date to 18 December.
On 13 Nov 2026, CBHB (09668.HK) completed the transfer of RMB 50.543 billion of loan claims to Tianjin Jinrong for RMB 35.4 billion, about 70% of face value.
On 13 Nov 2026, ZHAOKE OPHTH-B (06622.HK) said China's NMPA approved its cyclosporine ophthalmic gel for tear secretion in dry eye disease, dosed once nightly.
On 13 Nov 2026, KINGBOARD HLDG (00148.HK) agreed to buy 123 Hoi Bun Road, Kwun Tong for HKD 2,700,000,000 as an investment property of 612,188 sq ft lettable.
On 13 Nov 2026, HANSOH PHARMA (03692.HK) licensed AilsynBio's AI platform to find oral cyclic peptides, with payments reaching RMB 317 million plus royalties.
On 13 Nov 2026, TENNOR THERAP-B (06872.HK) extended to 31 July 2027 the deadline for China approval under its rifasutenizol deal with Grand Life Sciences.
On 13 Nov 2026, CHINA BOTON (03318.HK) said unit Shenzhen Boton will inject RMB 160 million for a 49% stake in Shandong Ganghong, booked as an associate.
On 13 Nov 2026, BJ ENT URBAN (03718.HK) won a Dali County sanitation project estimated at RMB 208.08 million, with yearly revenue of RMB 69.36 million.
On 13 Nov 2026, XINHUA WINSHARE (00811.HK) said state asset approval was granted for its RMB 345,747,000 purchase of Sichuan Nationalities Publishing House.
On 13 Nov 2026, SSY GROUP (02005.HK) said China's NMPA cleared its bevantolol hydrochloride as an API for marketed formulations, the third domestic approval.
On November 13, the HSI fell 1.55% and the HSTECH 3.02%, with CHINA RUYI up 10.23% and METIS TECHBIO-P down 19.69%; southbound bought HK$2.333 billion net.
Printed By: NewTimeSpace Media Limited
Address: 19H Maxgrand Plaza, No.3 Tai Yau Street, San Po Kong, Kowloon,HK
Email: contact@newtimespace.com
On 13 Nov 2026, CLOUD FACTORY (02512.HK) disclosed RMB96m and RMB145m server buys, both discloseable transactions with equipment delivered.
On 13 Nov 2026, BOCOM INTL (03329.HK) said its unit bought US$12m of Standard Chartered notes at 99.386 for about HK$93.6m, a discloseable transaction.
On 13 Nov 2026, LINGBAO GOLD (03330.HK) detailed a A$410m cash-plus-royalty deal for the remaining 50%-1 stake, with NSR royalties capped at A$244m.
On 13 Nov 2026, JLMAG (06680.HK) said its 20,000-tonne Baotou magnet project passed fire inspection; capacity will reach 60,000 tonnes a year by end-2027.
On 13 Nov 2026, HOPE LIFE INT (01683.HK) delayed its circular on the convertible bond deal to 20 November and extended the long-stop date to 18 December.
On 13 Nov 2026, CBHB (09668.HK) completed the transfer of RMB 50.543 billion of loan claims to Tianjin Jinrong for RMB 35.4 billion, about 70% of face value.
On 13 Nov 2026, ZHAOKE OPHTH-B (06622.HK) said China's NMPA approved its cyclosporine ophthalmic gel for tear secretion in dry eye disease, dosed once nightly.
On 13 Nov 2026, KINGBOARD HLDG (00148.HK) agreed to buy 123 Hoi Bun Road, Kwun Tong for HKD 2,700,000,000 as an investment property of 612,188 sq ft lettable.
On 13 Nov 2026, HANSOH PHARMA (03692.HK) licensed AilsynBio's AI platform to find oral cyclic peptides, with payments reaching RMB 317 million plus royalties.
On 13 Nov 2026, TENNOR THERAP-B (06872.HK) extended to 31 July 2027 the deadline for China approval under its rifasutenizol deal with Grand Life Sciences.
On 13 Nov 2026, CHINA BOTON (03318.HK) said unit Shenzhen Boton will inject RMB 160 million for a 49% stake in Shandong Ganghong, booked as an associate.
On 13 Nov 2026, BJ ENT URBAN (03718.HK) won a Dali County sanitation project estimated at RMB 208.08 million, with yearly revenue of RMB 69.36 million.
On 13 Nov 2026, XINHUA WINSHARE (00811.HK) said state asset approval was granted for its RMB 345,747,000 purchase of Sichuan Nationalities Publishing House.
On 13 Nov 2026, SSY GROUP (02005.HK) said China's NMPA cleared its bevantolol hydrochloride as an API for marketed formulations, the third domestic approval.
On November 13, the HSI fell 1.55% and the HSTECH 3.02%, with CHINA RUYI up 10.23% and METIS TECHBIO-P down 19.69%; southbound bought HK$2.333 billion net.
Printed By: NewTimeSpace Media Limited
Address: 19H Maxgrand Plaza, No.3 Tai Yau Street, San Po Kong, Kowloon,HK
Email: contact@newtimespace.com
本页为82搜索生成的网页快照，内容来自站内索引；演示数据的原文链接仅作示例。